Viewing Study NCT04098068


Ignite Creation Date: 2025-12-24 @ 5:46 PM
Ignite Modification Date: 2026-07-19 @ 2:17 AM
Study NCT ID: NCT04098068
Status: COMPLETED
Last Update Posted: 2025-03-30
First Post: 2019-09-19
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Study of MK-3475 (Pembrolizumab) in Patients With Microsatellite Unstable (MSI) Tumors (Cohort D)
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: J1365 (Cohort D)
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None INDUSTRY View